Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Momenta Pharmaceuticals Inc (MNTA) Com Stk USD0.0001

Sell:$52.36 Buy:$52.37 Change: $0.11 (0.21%)
NASDAQ:0.13%
Market closed |  Prices as at close on 21 September 2020 | Switch to live prices |
Tender Offer

Momenta Pharmaceuticals Inc Com Stk USD0.0001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 21 Sep 2020)

What is happening?

 

Vigor Sub Inc (a wholly owned subsidiary of Johnson & Johnson) recently announced a Takeover Offer for the entire outstanding issued Share Capital of Momenta Pharmaceuticals Inc. The Takeover is being done by way of a Tender Offer, under which you have been offered USD52.50 for each Momenta Pharmaceuticals Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD52.50 for each Momenta Pharmaceuticals Inc Share held. The deadline to submit an instruction is 9:00am on Thursday 24 September 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Please note that a firm date for settlement of the proceeds has not been announced.

 

How to make your choice

 

If you wish to give an instruction to accept Option 2 please provide your instructon below. Please note that instruction must be received by 9:00am on Thursday 24 September 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$52.36
Buy:$52.37
Change: $0.11 (0.21%)
Market closed |  Prices as at close on 21 September 2020 | Switch to live prices |
Tender Offer

Momenta Pharmaceuticals Inc Com Stk USD0.0001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 21 Sep 2020)

What is happening?

 

Vigor Sub Inc (a wholly owned subsidiary of Johnson & Johnson) recently announced a Takeover Offer for the entire outstanding issued Share Capital of Momenta Pharmaceuticals Inc. The Takeover is being done by way of a Tender Offer, under which you have been offered USD52.50 for each Momenta Pharmaceuticals Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD52.50 for each Momenta Pharmaceuticals Inc Share held. The deadline to submit an instruction is 9:00am on Thursday 24 September 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Please note that a firm date for settlement of the proceeds has not been announced.

 

How to make your choice

 

If you wish to give an instruction to accept Option 2 please provide your instructon below. Please note that instruction must be received by 9:00am on Thursday 24 September 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:$52.36
Buy:$52.37
Change: $0.11 (0.21%)
Market closed |  Prices as at close on 21 September 2020 | Switch to live prices |
Tender Offer

Momenta Pharmaceuticals Inc Com Stk USD0.0001

Type:
Tender Offer
Shareholder action required:
Yes
Status:
Client deadline
Details (last updated 21 Sep 2020)

What is happening?

 

Vigor Sub Inc (a wholly owned subsidiary of Johnson & Johnson) recently announced a Takeover Offer for the entire outstanding issued Share Capital of Momenta Pharmaceuticals Inc. The Takeover is being done by way of a Tender Offer, under which you have been offered USD52.50 for each Momenta Pharmaceuticals Inc Share held.

 

What are my options?

 

Option 1 – Do nothing. You are not required to take any action at this time. Depending on the level of acceptance the bidder may seek to delist and/or compulsory acquire any remaining Shares at a later date.

 

Option 2 – Accept the Offer. You can give an instruction to accept the Tender Offer of USD52.50 for each Momenta Pharmaceuticals Inc Share held. The deadline to submit an instruction is 9:00am on Thursday 24 September 2020. Following receipt of your instruction your Shares would be submitted in acceptance of the Offer. Please note that a firm date for settlement of the proceeds has not been announced.

 

How to make your choice

 

If you wish to give an instruction to accept Option 2 please provide your instructon below. Please note that instruction must be received by 9:00am on Thursday 24 September 2020.

 

Full details of this event will be sent to qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

Company announcements Announcements

No company announcements about Momenta Pharmaceuticals Inc Com Stk USD0.0001 were found.


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2020. All rights reserved.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.